Valentín Bote Pérez

I am a child and adolescent psychiatrist specialising in neurodevelopmental disorders. I was the lead clinician at the Terrassa Autism Unit for five years and have contributed to various research articles on autism and pharmacogenetics. I am currently part of the team at SJD Barcelona Children's Hospital.

Training

• Specialist in child and adolescent psychiatry.
• Psychiatry residency at Consorci Sanitari del Maresme.
• Bachelor of Medicine by Universidad Autónoma de Madrid.

International experience

I specialised in autism through a three-month external placement at the CAN CLINIC at UCLA in California.

Scientific activity

• Bote, V., Ayats, M., Sánchez, J., Martinez, J., Viñas, M., Medina, R., & Hervás, A. (2025). Experience in emotional support through psychotherapeutic support groups for mothers of children with autism spectrum disorder and intellectual disability at Mútua de Terrassa University Hospital. Revista De Psiquiatría Infanto-Juvenil, 42(1), 3–11.
• Alvarez A, Bote V, Lamborena C, Medina R, Serra-LLovich A, Hervas A, Arranz MJ. Review of pharmacogenomics of psychiatric comorbidities in autism spectrum disorder. Pharmacogenomics. 2023 Sep;24(14):781-791. doi: 10.2217/pgs-2023-0134. Epub 2023 Sep 28. PMID: 37767654.
• Arranz MJ, Salazar J, Bote V, Artigas-Baleri A, Serra-LLovich A, Triviño E, Roige J, Lombardia C, Cancino M, Hernandez M, Cendros M, Duran-Tauleria E, Maraver N, Hervas A. Pharmacogenetic Interventions Improve the Clinical Outcome of Treatment-Resistant Autistic Spectrum Disorder Sufferers. Pharmaceutics. 2022 May 6;14(5):999. doi: 10.3390/pharmaceutics14050999. PMID: 35631585; PMCID: PMC9143818.
• Hernandez MH, Bote V, Serra-LLovich A, Cendros M, Salazar J, Mestres C, Guijarro S, Alvarez A, Lamborena C, Mendez I, Sanchez B, Hervas A, Arranz MJ. CES1 and SLC6A2 Genetic Variants As Predictors of Response To Methylphenidate in Autism Spectrum Disorders. Pharmgenomics Pers Med. 2022 Nov 8;15:951-957. doi: 10.2147/PGPM.S377210. PMID: 36393977; PMCID: PMC9653043.